FEVER OF UNKNOWN ORIGIN Flashcards
FUO is now defined as
- Fever ≥38.3C (≥101 F) on at least two occasions
- Illness duration of ≥3 weeks
- No known immunocompromised state
- Diagnosis that remains uncertain after a thorough history-taking, physical examination, and the obligatory investigations
- ESR and CRP
- CBC
- electrolytes, creatinine
- total protein
- AST, ALT, Alk phos
- lactate dehydrogenase
- creatine kinase
- ferritin
- ANA and RF
- protein electrophoresis
- urinalysis
- blood cultures (n = 3)
- urine culture
- chest x-ray
- abdominal ultrasonography
- TST or IGRA
Up to half of all infections in patients with FUO outside Western nations are caused by ____________
M. tuberculosis
The most common diagnosis of FUO among the neoplasms
Malignant lymphoma
Fever artificially induced by the patient—for example, by IV injection of contaminated water
Factitious fever
Is the term when the patient is normothermic but manipulates the thermometer
Fraudulent fever
TRUE OR FALSE: FUO in the elderly results from an atypical manifestation of a common disease
TRUE
- FUO in the elderly results from an atypical manifestation of a common disease, among which giant cell arteritis and polymyalgia rheumatica are most frequently involved
The most common infectious disease associated with FUO in elderly patients
Tuberculosis
TRUE OR FALSE: Performing more than three blood cultures or more than one urine culture is useless in patients with FUO in the absence of PDCs
TRUE
- Repeating blood or urine cultures is useful only when previously cultured samples were collected during antibiotic treatment or within 1 week after its discontinuation
TRUE OR FALSE: Patients should be asked to return during a febrile episode so that the history, physical examination, and laboratory tests can be repeated during a symptomatic phase
TRUE
- In patients with recurrent fever lasting >2 years, it is very unlikely that the fever is caused by infection or malignancy.
TRUE OR FALSE: Empirical therapeutic trials with antibiotics, glucocorticoids, or antituberculous agents should be avoided in FUO except when a patient’s condition is rapidly deteriorating
TRUE
- Antibiotic or antituberculous therapy may irrevocably diminish the ability to culture fastidious bacteria or mycobacteria
When to initiate empiric antibiotic treatment in patients with FUO?
Hemodynamic instability or neutropenia is a good indication for empirical antibiotic therapy
When to start a trial of therapy for tuberculosis?
If TST or IGRA is positive or if granulomatous disease is present with anergy and sarcoidosis seems unlikely
- If the fever does not respond after 6 weeks of empirical antituberculous treatment, another diagnosis should be considered.
TRUE OR FALSE: In patients in whom FUO remains unexplained, prognosis is favorable
TRUE
- FUO-related mortality rates have continuously declined over recent decades
- the risk of death related to FUO is dependent on the underlying disease
A trial of what drug can be considered in patients whose FUO has not been diagnosed after later-stage diagnostic tests
Therapeutic trials with ANAKINRA can be considered in patients whose FUO has not been diagnosed after later-stage diagnostic tests
- Anakinra, a recombinant form of the naturally occurring IL-1 receptor antagonist (IL-1Ra), blocks the activity of both IL-1α and IL-1β.
Characterized by urticaria, bone pain, and monoclonal gammopathy
Schnitzler syndrome